Seguimiento de transacciones de insiders en los distintos mercados.
| 30 días | 90 días | 120 días | |
|---|---|---|---|
| Rentabilidad media | 31% | 8.2% | 15.1% |
| Tasa de éxito | 100% | 68% | 82% |
| Transacciones |
1
100% Comprar
|
34
71% Comprar
|
47
69% Comprar
|
| Posición | Compañía | Período |
|---|---|---|
| Director | Salarius Pharmaceuticals Inc | 22 de julio de 2019 - |
| President, Chief Executive Officer, Director | Salarius Pharmaceuticals Inc | 23 de agosto de 2017 - 19 de julio de 2019 |
| President, Chief Executive Officer | Salarius Pharmaceuticals Inc | 31 de julio de 2017 - 23 de agosto de 2017 |
| Interim President, Interim Chief Executive Officer | Salarius Pharmaceuticals Inc | 3 de julio de 2017 - 31 de julio de 2017 |
| President - Research and Development | Salarius Pharmaceuticals Inc | 5 de abril de 2017 - 3 de julio de 2017 |
| Executive Vice President, Chief Scientific Officer | Rocket Pharmaceuticals Inc | None - |
Buscar